Abstract
In cystic fibrosis (CF), actin and DNA originating from inflammatory cells contribute to the thickness of airway secretions. Actin can bind to DNA-rich fibers and potently inhibit the enzymatic activity of rhDNase. The in vitro effects of the actin-resistant rhDNase variant (A114R) were analyzed and compared with those of the wild-type rhDNase. Frozen and thawed CF airway secretions were incubated for 30 min with different concentrations (0.1, 0.5, 1, 5, or 10 microg/ml) of either actin-resistant rhDNase or wild-type rhDNase. We observed that both the wild-type and the actin-resistant rhDNase significantly decreased (p < 0.05 and p < 0.001, respectively) the airway secretion viscosity. The decrease in airway secretion viscosity was significant even at low concentrations (0.1 microg/ml) of the actin-resistant variant. Incubation with the actin-resistant variant resulted in a significant decrease (p < 0.02) of the airway secretion contact angle and cough transport. A significantly higher (p < 0.01) increase in contact angle and cough transport of airway secretions was observed at 10 microg/ml with the actin-resistant variant as compared with the wild-type rhDNase. The present study had demonstrated that the actin-resistant rhDNas...Continue Reading
References
Nov 1, 1990·The American Review of Respiratory Disease·M I LethemC Marriott
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S ShakC L Baker
Apr 30, 1987·Clinica Chimica Acta; International Journal of Clinical Chemistry·C GalabertE Puchelle
Jan 1, 1985·Biorheology·E PuchelleD Quemada
Jun 1, 1985·Journal of Applied Physiology·M KingC Lundell
Dec 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·E Lazarides, U Lindberg
Mar 1, 1995·The European Respiratory Journal·J M ZahmE Puchelle
May 6, 1994·Science·T T PerkinsS Chu
Feb 18, 1994·Science·C A VasconcellosT P Stossel
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·J S UlmerR A Lazarus
Jun 3, 1997·Biochemistry·C Q Pan, R A Lazarus
Aug 12, 1997·Biochemistry·K DavoodianM R Bubb
Apr 16, 1998·Gene Therapy·M SternE W Alton
Jun 13, 1998·The Journal of Biological Chemistry·C Q Pan, R A Lazarus
Jun 25, 1998·American Journal of Respiratory and Critical Care Medicine·J M ZahmE Puchelle
Jul 11, 1998·The Journal of Biological Chemistry·C Q PanR A Lazarus
Apr 20, 1999·Chest·B K Rubin
Oct 26, 1999·Infection and Immunity·D DacheuxB Toussaint
Jun 22, 2000·Pediatric Pulmonology·M RobinsonP T Bye
Jul 1, 1958·A.M.A. Journal of Diseases of Children·H SHWACHMAN, L L KULCZYCKI
Citations
Jun 17, 2011·The Journal of Membrane Biology·Vasily V Kuvichkin
Nov 6, 2009·Gene Therapy·C MuellerD S Strayer
Oct 31, 2006·Thorax·N N SandersJ Demeester
Mar 5, 2002·American Journal of Respiratory and Critical Care Medicine·Martin J Tobin
Jun 4, 2011·PloS One·Kaoru HidaJustin Hanes
Aug 14, 2012·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Junko FujiharaHaruo Takeshita
Apr 3, 2010·International Immunopharmacology·Ya-Juan ChenFu-Qiang Wen
Nov 29, 2005·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Junko FujiharaHaruo Takeshita
Oct 15, 2011·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Reinhard ManzenreiterDominik Hartl
May 15, 2007·Annals of the New York Academy of Sciences·Arnon KaterBruce K Rubin
Jan 28, 2017·Biotechnology Progress·Cynthia LamShahram Misaghi
Apr 4, 2021·Biomolecules·Danila DelfinoRiccardo Percudani